Vol 79, Supp. IV (2021): Zeszyty Edukacyjne 4/2021
Opinie i stanowiska ekspertów
Published online: 2021-11-26

open access

Page views 3162
Article views/downloads 4743
Get Citation

Connect on Social Media

Connect on Social Media

Przezskórna naprawa zastawki trójdzielnej metodą brzeg-do-brzegu — kwalifikacja pacjentów, obrazowanie, techniki zabiegowe. Opinia ekspertów Sekcji Echokardiografii i Asocjacji Interwencji Sercowo-Naczyniowych Polskiego Towarzystwa Kardiologicznego

Adam Rdzanek1, Piotr Szymański2, Andrzej Gackowski3, Piotr Scisło1, Jerzy Pręgowski4, Arkadiusz Pietrasik1, Jarosław Trębacz5, Karol Zbroński1, Janusz Kochman1, Adam Witkowski4, Wojciech Wojakowski6, Marek Grygier7
DOI: 10.33963/v.kp.87141

Abstract

Niedomykalność trójdzielna (TR, tricuspid regurgitation) jest częstą nabytą wadą serca. Jest chorobą postępującą i związaną z pogorszeniem długoterminowego rokowania zarówno u objawowych, jak i bezobjawowych pacjentów. Pomimo tych danych łączna liczba wykonywanych na świecie chirurgicznych napraw zastawki trójdzielnej jest mała, a wielu pacjentów z istotnymi wskazaniami pozostaje bez leczenia. Stosowane na coraz większą skalę małoinwazyjne techniki przezcewnikowe mogą stać się atrakcyjną opcją terapeutyczną dla tej rosnącej grupy pacjentów. Spośród dostępnych metod leczenia przezskórnego naprawa metodą brzeg-do-brzegu zyskuje w ostatnim czasie na znaczeniu. W niniejszym artykule podsumowano aktualną wiedzę dotyczącą tej metody leczenia.

References

  1. Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019; 12(3): 433–442.
  2. Silbiger JJ. Atrial functional tricuspid regurgitation: An underappreciated cause of secondary tricuspid regurgitation. Echocardiography. 2019; 36(5): 954–957.
  3. Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol. 2009; 53(5): 401–408.
  4. Bannehr M, Edlinger CR, Kahn U, et al. Natural course of tricuspid regurgitation and prognostic implications. Open Heart. 2021; 8(1): e001529.
  5. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014; 7(12): 1185–1194.
  6. Wang N, Fulcher J, Abeysuriya N, et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2019; 40(5): 476–484.
  7. Bartko PE, Arfsten H, Frey MK, et al. Natural history of functional tricuspid regurgitation: implications of quantitative Doppler assessment. JACC Cardiovasc Imaging. 2019; 12(3): 389–397.
  8. Schueler R, Öztürk C, Sinning JM, et al. Impact of baseline tricuspid regurgitation on long-term clinical outcomes and survival after interventional edge-to-edge repair for mitral regurgitation. Clin Res Cardiol. 2017; 106(5): 350–358.
  9. Geyer M, Keller K, Bachmann K, et al. Concomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repair. Clin Res Cardiol. 2021; 110(5): 676–688.
  10. Wengenmayer T, Zehender M, Bothe W, et al. First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system. EuroIntervention. 2016; 11(13): 1541–1544.
  11. Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017; 135(19): 1802–1814.
  12. Orban M, Rommel KP, Ho EC, et al. Transcatheter edge-to-edge tricuspid repair for severe tricuspid regurgitation reduces hospitalizations for heart failure. JACC Heart Fail. 2020; 8(4): 265–276.
  13. Cai S, Bowers N, Dhoot A, et al. Natural history of severe tricuspid regurgitation: Outcomes after transcatheter tricuspid valve intervention compared to medical therapy. Int J Cardiol. 2020; 320: 49–54.
  14. Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632.
  15. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143(5): e35–e71.
  16. Mehr M, Karam N, Taramasso M, et al. Combined tricuspid and mitral versus isolated mitral valve repair for severe mr and TR: an analysis from the trivalve and TRAMI registries. JACC Cardiovasc Interv. 2020; 13(5): 543–550.
  17. Taramasso M, Hahn RT, Alessandrini H, et al. The international multicenter trivalve registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc Interv. 2017; 10(19): 1982–1990.
  18. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004; 127(3): 674–685.
  19. Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017; 18(12): 1342–1343.
  20. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143(5): e72–e227.
  21. Hahn RT. A review of imaging options relevant to treating functional tricuspid regurgitation with transcatheter techniques. Cardiac Interventions Today. 2017; 11(4): 40–47.
  22. Instructions for Use TriclipTM System. https://vascular.eifu.abbott/en/detail-screen.html (6.05.2021).
  23. Instructions for use Edwards PASCAL Transcatheter Valve Repair System. https://eifu.edwards.com/eifu/pages/viewers/pdf?projectKey=5e7e4f5d87b3940001e289be&itemKey=605bd73ab4147f0001900c76 (6.05.2021).
  24. Karam N, Mehr M, Taramasso M, et al. Value of echocardiographic right ventricular and pulmonary pressure assessment in predicting transcatheter tricuspid repair outcome. JACC Cardiovasc Interv. 2020; 13(10): 1251–1261.
  25. Besler C, Orban M, Rommel KP, et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc Interv. 2018; 11(12): 1119–1128.
  26. Mehr M, Taramasso M, Besler C, et al. 1-year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the trivalve registry. JACC Cardiovasc Interv. 2019; 12(15): 1451–1461.
  27. Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international trivalve registry. JACC Cardiovasc Interv. 2019; 12(2): 155–165.
  28. Nickenig G, Weber M, Lurz P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet. 2019; 394(10213): 2002–2011.
  29. Lurz P, Stephan von Bardeleben R, Weber M, et al. TRILUMINATE Investigators. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021; 77(3): 229–239.
  30. Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 2017; 390(10096): 773–780.
  31. Lim DS, Kar S, Spargias K, et al. Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study. JACC Cardiovasc Interv. 2019; 12(14): 1369–1378.
  32. Webb JG, Hensey M, Szerlip M, et al. 1-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. JACC Cardiovasc Interv. 2020; 13(20): 2344–2357.
  33. Fam NP, Braun D, von Bardeleben RS, et al. Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv. 2019; 12(24): 2488–2495.
  34. Kodali S, Hahn RT, Eleid MF, et al. CLASP TR EFS Investigators. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol. 2021; 77(4): 345–356.



Polish Heart Journal (Kardiologia Polska)